Innovative treatment option

Nov. 1, 1998
Block Drug Corporation has approval to use Atridox™ (10.0% doxycycline hyclate) in the ATRIGEL® delivery system for the treatment of periodontal disease. Atridox™ offers a new treatment option that is both effective and comfortable for the millions of Americans plagued with infected, inflamed gums associated with periodontal disease.

Block Drug Corporation has approval to use Atridox™ (10.0% doxycycline hyclate) in the ATRIGEL® delivery system for the treatment of periodontal disease. Atridox™ offers a new treatment option that is both effective and comfortable for the millions of Americans plagued with infected, inflamed gums associated with periodontal disease.

Atridox™ combines the antibiotic doxycycline with a unique gel that the dentist applies to periodontal pockets to fight the bacteria that cause this chronic infection in adults. Atridox™ continuously releases the antibiotic over seven days to safely fight the periodontal infection.

For more details, contact Block Drug Corporation at (800) 365-6500.

Sponsored Recommendations

Clinical Study: OraCare Reduced Probing Depths 4450% Better than Brushing Alone

Good oral hygiene is essential to preserving gum health. In this study the improvements seen were statistically superior at reducing pocket depth than brushing alone (control ...

Clincial Study: OraCare Proven to Improve Gingival Health by 604% in just a 6 Week Period

A new clinical study reveals how OraCare showed improvement in the whole mouth as bleeding, plaque reduction, interproximal sites, and probing depths were all evaluated. All areas...

Chlorine Dioxide Efficacy Against Pathogens and How it Compares to Chlorhexidine

Explore our library of studies to learn about the historical application of chlorine dioxide, efficacy against pathogens, how it compares to chlorhexidine and more.

Enhancing Your Practice Growth with Chairside Milling

When practice growth and predictability matter...Get more output with less input discover chairside milling.